Evaluation of the Tolerability and Safety of 0.015% Ingenol Mebutate Gel Compared to 5% 5-fluorouracil Cream for the Treatment of Facial Actinic Keratosis: a Prospective Randomized Trial

Trial Profile

Evaluation of the Tolerability and Safety of 0.015% Ingenol Mebutate Gel Compared to 5% 5-fluorouracil Cream for the Treatment of Facial Actinic Keratosis: a Prospective Randomized Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2015

At a glance

  • Drugs Ingenol mebutate (Primary) ; Fluorouracil
  • Indications Actinic keratosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Mar 2015 Results presented at the 73rd Annual Meeting of the American Academy of Dermatology.
    • 23 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top